LSL Web-Exclusive Content

  1. Survey Results Show What Could Finally Make Sustainability Stick 9/8/2023

    Results from BioPlan's "20th Annual Report of Biopharmaceutical Manufacturing and Production" show that lasting sustainability strategies should focus on profitability aspects. That's because, even more than a spirit of stewardship, financial advantages provide a powerful incentive to stick to the plan.

  2. Cautious Optimism For Biotechs And Their Outsourcing Partners 9/5/2023

    Pre-revenue, including preclinical and clinical stage, biotechs have been the most impacted but also stand to gain the most after the economic downturn and subsequent recovery. This article will delve into how small to midsize pre-revenue biotechs have been specifically impacted and what this could mean for organizations that support them.

  3. 5 Best Practices For Responding To FDA Form 483 Inspection Observations 9/1/2023

    How you respond to FDA Form 483 observations will determine if they escalate into more serious consequences, such as a warning letter or enforcement action. You don't want that. Follow this 5-step action plan to make sure the findings are properly addressed.

  4. Efficient Biotech Vendor Selection And Management During Economic Uncertainty 8/30/2023

    To navigate these turbulent economic waters effectively, we must view this funding crunch as a push for creativity and resiliency. This present moment requires a strategy integrating savvy financial management and strategic vendor selection to ensure a thriving biotech.

  5. When Workers Are Down, Clinical Leaders Must Rise Up 8/30/2023

    There's no surprise in saying that sponsors, CROs, and sites alike are experiencing a worker shortage. To help mitigate some of those troubles, ASC Therapeutics CMO Oscar Segurado, MD, PhD outlines some ways in which clinical research leaders can attract and retain staff and mitigate burnout.

  6. Unboxing Genentech's New Clinical Supply Center 8/28/2023

    Genentech’s Clinical Supply Center, which opened in 2022 in South San Francisco, earned the company an ISPE Facility of the Year Award in the Pharma 4.0 category. This Q&A, the third in a series featuring FOYA winners, explores the strategy behind a central manufacturing site for clinical manufacturing.

  7. 4 Ways To Gain A Competitive Edge In This Bio/Pharma Talent Shortage 8/25/2023

    It’s no secret that finding pharma/biotech manufacturing talent is challenging, and the lack of workers is having a negative impact on productivity and growth. Here are four effective strategies for recruiting, training, educating, and retaining your workforce.

  8. The Biosimilar Playbook On PBMs 8/24/2023

    There was a general sentiment amongst the PBMs that, at least in the beginning, Humira would remain in a preferred position alongside some combination of biosimilars. It is likely the ambiguity was intentional to encourage further competition amongst the new entrants.

  9. Keys To Success For Today's Health Care Startups 8/18/2023

    By sticking first to principles and focusing on empowering teams, healthcare startups can navigate the unique pressures they face and emerge stronger and more successful from today’s economic headwinds.

  10. Navigating The Storm: The Inner Strength Of Leadership 8/16/2023

    Steering others, motivating a team, and making pivotal decisions hinge on a vital skill: self-leadership. This quality becomes your anchor, especially in turbulent times of uncertainty or adversity.